Arrowhead Pharmaceuticals Inc. (ARWR) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

ARWR ratio: 32%

100%

ARWR beat 11 of 34 last estimates

Date of next report: Dec 4, 2024

Estimate for Q3 24: $-0.23

Implied change from Q2 24: -83.33%

Implied change from Q3 23: -77.67%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q2 24	Aug 8, 2024	$-1.38 / $-0.58	$-0.8 / -137.93%
Q1 24	May 9, 2024	$-1.02 / $-0.06	$-0.96 / -1600%
Q4 23	Feb 6, 2024	$-1.24 / $-0.78	$-0.46 / -58.97%
Q3 23	Nov 29, 2023	$-1.03 / $-0.7	$-0.33 / -47.14%
Q2 23	Aug 7, 2023	$-0.96 / $-0.58	$-0.38 / -65.52%
Q1 23	May 2, 2023	$0.45 / $-0.65	$1.1 / 169.23%
Q4 22	Feb 6, 2023	$-0.39 / $1.14	$-1.53 / -134.21%
Q3 22	Nov 28, 2022	$-0.81 / $-0.57	$-0.24 / -42.11%

Data Vendor: Xignite Logo